Gene therapy with AAV2-CDNF provides functional benefits in a rat model of Parkinson's disease
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Gene therapy with AAV2-CDNF provides functional benefits in a rat model of Parkinson's disease
Authors
Keywords
-
Journal
Brain and Behavior
Volume 3, Issue 2, Pages 75-88
Publisher
Wiley
Online
2013-01-14
DOI
10.1002/brb3.117
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- GDNF fails to exert neuroprotection in a rat -synuclein model of Parkinson's disease
- (2011) M. Decressac et al. BRAIN
- CDNF Protects the Nigrostriatal Dopamine System and Promotes Recovery after MPTP Treatment in Mice
- (2011) Mikko Airavaara et al. CELL TRANSPLANTATION
- AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial
- (2011) Peter A LeWitt et al. LANCET NEUROLOGY
- Chronic infusion of CDNF prevents 6-OHDA-induced deficits in a rat model of Parkinson's disease
- (2010) Merja H. Voutilainen et al. EXPERIMENTAL NEUROLOGY
- Mesencephalic Astrocyte-derived Neurotrophic Factor (MANF) Has a Unique Mechanism to Rescue Apoptotic Neurons
- (2010) Maarit Hellman et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Characterization of the Intracellular Localization, Processing, and Secretion of Two Glial Cell Line-Derived Neurotrophic Factor Splice Isoforms
- (2010) L. Lonka-Nevalaita et al. JOURNAL OF NEUROSCIENCE
- Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial
- (2010) William J Marks et al. LANCET NEUROLOGY
- Anterograde Axonal Transport of AAV2-GDNF in Rat Basal Ganglia
- (2010) Agnieszka Ciesielska et al. MOLECULAR THERAPY
- Gene therapy for Parkinson's disease
- (2010) Tomas Bjorklund et al. MOVEMENT DISORDERS
- Bioactivity of AAV2-neurturin gene therapy (CERE-120): Differences between Parkinson's disease and nonhuman primate brains
- (2010) Raymond T. Bartus et al. MOVEMENT DISORDERS
- Clinically Relevant Effects of Convection-Enhanced Delivery of AAV2-GDNF on the Dopaminergic Nigrostriatal Pathway in Aged Rhesus Monkeys
- (2009) Louisa C. Johnston et al. HUMAN GENE THERAPY
- Mesencephalic Astrocyte-Derived Neurotrophic Factor Is Neurorestorative in Rat Model of Parkinson's Disease
- (2009) M. H. Voutilainen et al. JOURNAL OF NEUROSCIENCE
- Evidence that DmMANF is an invertebrate neurotrophic factor supporting dopaminergic neurons
- (2009) M. Palgi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The structure of the conserved neurotrophic factors MANF and CDNF explains why they are bifunctional
- (2009) Vimal Parkash et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2–neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial
- (2008) William J Marks et al. LANCET NEUROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now